NASDAQ:HCAT Health Catalyst (HCAT) Stock Price, News & Analysis $1.29 0.00 (0.00%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$1.29 0.00 (0.00%) As of 05/22/2026 05:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Health Catalyst Stock (NASDAQ:HCAT) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Health Catalyst alerts:Sign Up Key Stats Today's Range$1.24▼$1.3350-Day Range$1.00▼$1.7952-Week Range$0.96▼$4.29Volume261,859 shsAverage Volume608,335 shsMarket Capitalization$95.32 millionP/E RatioN/ADividend YieldN/APrice Target$2.77Consensus RatingHold Company Overview Health Catalyst (NASDAQ: HCAT) is a healthcare data and analytics technology company founded in 2008 and headquartered in Salt Lake City, Utah. The company went public in 2019 and has since focused on delivering a unified data platform that helps healthcare organizations aggregate and analyze clinical, financial and operational information. The core of Health Catalyst’s offering is the Data Operating System (DOS), a modular data management platform that integrates disparate data sources—from electronic health records to claims and patient-generated data—into a single analytics environment. Built on cloud-native architecture, DOS provides analytics applications and tools for care management, performance improvement, population health and financial analysis. In addition to its platform technology, Health Catalyst provides professional services including implementation support, data engineering, performance improvement consulting and change management. These services are designed to help health systems and hospitals accelerate adoption of data-driven practices, improve clinical quality and reduce costs through evidence-based interventions. Health Catalyst serves more than 450 healthcare organizations across the United States and has expanded its footprint into select international markets. The company is led by an executive team with deep experience in health IT and population health, and it partners with clients ranging from community hospitals to large integrated health systems to drive measurable improvements in patient outcomes and operational efficiency.AI Generated. May Contain Errors. Read More Health Catalyst Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks46th Percentile Overall ScoreHCAT MarketRank™: Health Catalyst scored higher than 46% of companies evaluated by MarketBeat, and ranked 572nd out of 869 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.1 / 5Analyst RatingHold Consensus RatingHealth Catalyst has received a consensus rating of Hold. The company's average rating score is 2.23, and is based on no strong buy ratings, 4 buy ratings, 8 hold ratings, and 1 sell rating.Upside PotentialHealth Catalyst has a consensus price target of $2.77, representing about 114.9% upside from its current price of $1.29.Amount of Analyst CoverageHealth Catalyst has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Health Catalyst's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Health Catalyst are expected to grow in the coming year, from ($0.28) to ($0.23) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Health Catalyst is -0.35, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Health Catalyst is -0.35, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioHealth Catalyst has a P/B Ratio of 0.69. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Health Catalyst's valuation and earnings. Short Interest0.0 / 5Short Interest LevelBearish Percentage of Shares Shorted10.58% of the float of Health Catalyst has been sold short.Short Interest Ratio / Days to CoverHealth Catalyst has a short interest ratio ("days to cover") of 13.87, which indicates bearish sentiment.Change versus previous monthShort interest in Health Catalyst has recently increased by 0.38%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldHealth Catalyst does not currently pay a dividend.Dividend GrowthHealth Catalyst does not have a long track record of dividend growth. News and Social Media1.1 / 5News Sentiment-0.18 News SentimentHealth Catalyst has a news sentiment score of -0.18. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.45 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Health Catalyst this week, compared to 3 articles on an average week. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Health Catalyst insiders have not sold or bought any company stock.Percentage Held by Insiders2.60% of the stock of Health Catalyst is held by insiders.Percentage Held by Institutions85.00% of the stock of Health Catalyst is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Health Catalyst's insider trading history. Receive HCAT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Health Catalyst and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. HCAT Stock News Headlines5 insightful analyst questions from Health Catalyst’s Q1 earnings callMay 18, 2026 | msn.comFinancial Survey: Alternate Health (OTCMKTS:AHGIF) versus Health Catalyst (NASDAQ:HCAT)May 18, 2026 | americanbankingnews.com$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s known for playing his cards “close to the vest”… Is going to give you the name and ticker symbol of a company he believes will skyrocket thanks to the coming Starlink IPO…May 25 at 1:00 AM | Paradigm Press (Ad)Analyzing Careview Communications (OTCMKTS:CRVW) and Health Catalyst (NASDAQ:HCAT)May 17, 2026 | americanbankingnews.comHealth Catalyst (NASDAQ:HCAT) and Azenta (NASDAQ:AZTA) Critical ContrastMay 17, 2026 | americanbankingnews.comHealth Catalyst (HCAT) Stock Trades Up, Here Is WhyMay 16, 2026 | finance.yahoo.comAnalysts Offer Insights on Healthcare Companies: Health Catalyst (HCAT) and Fisher & Paykel Healthcare Corporation Limited (OtherFSPKF)May 14, 2026 | theglobeandmail.comHealth Catalyst Inc (HCAT) Q1 2026 Earnings Call Highlights: Surpassing Expectations with ...May 12, 2026 | finance.yahoo.comSee More Headlines HCAT Stock Analysis - Frequently Asked Questions How have HCAT shares performed this year? Health Catalyst's stock was trading at $2.39 at the beginning of the year. Since then, HCAT stock has decreased by 46.0% and is now trading at $1.29. How were Health Catalyst's earnings last quarter? Health Catalyst, Inc. (NASDAQ:HCAT) issued its earnings results on Monday, May, 11th. The company reported $0.02 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.01 by $0.01. The firm had revenue of $70.76 million for the quarter, compared to analysts' expectations of $69.24 million. Health Catalyst had a negative trailing twelve-month return on equity of 3.52% and a negative net margin of 87.69%. Read the conference call transcript. When did Health Catalyst IPO? Health Catalyst (HCAT) raised $172 million in an IPO on Wednesday, July 24th 2019. The company issued 7,000,000 shares at $24.00-$25.00 per share. Goldman Sachs, J.P. Morgan and William Blair acted as the underwriters for the IPO and Piper Jaffray, Evercore ISI, SVB Leerink and SunTrust Robinson Humphrey were co-managers. Who are Health Catalyst's major shareholders? Health Catalyst's top institutional shareholders include First Light Asset Management LLC (17.43%), Dimensional Fund Advisors LP (1.68%), Renaissance Technologies LLC (0.29%) and Sei Investments Co. (0.23%). Insiders that own company stock include Bryan Truman Hunt, Kevin Lee Freeman, Daniel Lesueur, Benjamin Landry, Jason Alger, Linda Llewelyn, Julie Larson-Green and Duncan Gallagher. View institutional ownership trends. How do I buy shares of Health Catalyst? Shares of HCAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Health Catalyst own? Based on aggregate information from My MarketBeat watchlists, some other companies that Health Catalyst investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), The RMR Group (RMR), AUO (AUOTY), Voyager Therapeutics (VYGR) and DiamondRock Hospitality (DRH). Company Calendar Last Earnings5/11/2026Today5/24/2026Next Earnings (Estimated)8/06/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (2w+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 For the last 2 weeks, HCAT's financial health has been in the Green zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MEDICAL INFO SYS Sub-IndustryComputer Software Current SymbolNASDAQ:HCAT CIK1636422 Webwww.healthcatalyst.com Phone(801) 708-6800FaxN/AEmployees1,200Year Founded2008Price Target and Rating Average Price Target for Health Catalyst$2.77 High Price Target$5.00 Low Price Target$1.00 Potential Upside/Downside+114.9%Consensus RatingHold Rating Score (0-4)2.23 Research Coverage13 Analysts Profitability EPS (Trailing Twelve Months)($3.72) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$177.97 million Net Margins-87.69% Pretax Margin-87.39% Return on Equity-3.52% Return on Assets-1.77% Debt Debt-to-Equity Ratio1.10 Current Ratio1.69 Quick Ratio1.69 Sales & Book Value Annual Sales$311.14 million Price / Sales0.31 Cash Flow$2.11 per share Price / Cash Flow0.61 Book Value$1.87 per share Price / Book0.69Miscellaneous Outstanding Shares73,890,000Free Float71,973,000Market Cap$95.32 million OptionableOptionable Beta1.63 Social Links Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (NASDAQ:HCAT) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredRead now. Do not delete. You’ve been warned.Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” P...Porter & Company | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Health Catalyst, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Health Catalyst With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
